Fundamental analysis · SEC EDGAR · TTM through 31/03/2026

Fundamental analysis of Metlife Inc

MET · NYSE · Financial

Fundamental quality

REASONABLE

59

out of 100

Breakdown by area

I.GrowthEPS growth: -5.9% · Revenue growth: 3.8%
26
II.ProfitabilityNet margin: 4.7% · ROE: 13.2%
57
III.Financial healthNet debt/EBITDA: -0.59x
95

Source: SEC EDGAR · TTM through 31/03/2026

The score combines growth, profitability and financial strength. Here its financial strength weighs in its favor, while its growth drags it down the most.

Strengths

  • Net cash position: more cash than debt.

Risks and weaknesses

  • Thin margins (net margin of 4.7%).
  • Declining earnings per share (-5.9% annualized).

Historical evolution

YearRevenueNet incomeFree cash flowNet debt
2021$68,696M$6,855M-$20,047M
2022$68,770M$5,284M-$20,195M
2023$66,905M$1,578M-$20,639M
2024$70,986M$4,426M-$20,068M
2025$77,084M$3,379M-$22,032M

Between 2021 and 2025, revenue went from $68,696M to $77,084M (+12%) and net income went from $6,855M to $3,379M (-51%).

Annual figures in U.S. dollars per SEC filings. Net debt is total debt minus cash.

Frequently asked questions

Is Metlife Inc a profitable company?

Metlife Inc is profitable, with a net margin of 4.7%, though a thin one.

Does Metlife Inc have a lot of debt?

No. Metlife Inc has a net cash position: more cash than debt.

Is Metlife Inc growing?

Its revenue has grown 3.8% annualized in recent years.

The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.

Is Metlife Inc cheap or expensive?

That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).

Compute the valuation →
Advertising

Where to buy Metlife Inc?

Brokers you can use to invest in U.S. and European stocks.

Compare the brokers →